Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Longview Acquisition Corp. II (LGV : NYSE)
 
 • Company Description   
Longview Acquisition Corp. II entered into a definitive business combination agreement with HeartFlow Holding Inc.

Number of Employees: 3

 
 • Price / Volume Information   
Yesterday's Closing Price: $10.09 Daily Weekly Monthly
20 Day Moving Average: 0 shares
Shares Outstanding: 86.25 (millions)
Market Capitalization: $870.26 (millions)
Beta: 0.04
52 Week High: $10.15
52 Week Low: $9.75
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 0.00% -3.79%
12 Week 0.00% -7.17%
Year To Date 0.00% -9.04%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
767 FIFTH AVENUE 44TH FLOOR
-
NEW YORK,NY 10153
USA
ph: 212-812-4700
fax: -
info@longviewacquisition.com http://www.longviewacquisition.com
 
 • General Corporate Information   
Officers
John Rodin - ChiefExecutiveOfficer
Larry Robbins - Chairman
Mark Horowitz - ChiefFinancialOfficer
Westley Moore - Director
Shalinee Sharma - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 54319Q105
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 86.25
Most Recent Split Date: (:1)
Beta: 0.04
Market Capitalization: $870.26 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 117.59
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/23 - -
12/31/22 - -
09/30/22 - -65.52
ROA
03/31/23 - -
12/31/22 - -
09/30/22 - 3.65
Current Ratio
03/31/23 - -
12/31/22 - -
09/30/22 - 0.07
Quick Ratio
03/31/23 - -
12/31/22 - -
09/30/22 - 0.07
Operating Margin
03/31/23 - -
12/31/22 - -
09/30/22 - -
Net Margin
03/31/23 - -
12/31/22 - -
09/30/22 - -
Pre-Tax Margin
03/31/23 - -
12/31/22 - -
09/30/22 - -
Book Value
03/31/23 - -
12/31/22 - -
09/30/22 - -0.38
Inventory Turnover
03/31/23 - -
12/31/22 - -
09/30/22 - -
Debt-to-Equity
03/31/23 - -
12/31/22 - -
09/30/22 - -
Debt-to-Capital
03/31/23 - -
12/31/22 - -
09/30/22 - -
 

Powered by Zacks Investment Research ©